Alzheimer’s disease could be slowed by boosting a certain protein in the brain, researchers say
Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...
SCNow1d
CareSouth patient one of the first in nation to receive Alzheimer's infusion
A CareSouth Carolina patient is among the first in the United States to receive a groundbreaking treatment aimed at slowing ...
BioSpace9d
Late-Stage Alzheimer’s Pipeline Goes Beyond Amyloid and Tau
The next generation of Alzheimer’s therapeutics is moving away from amyloid plaques and tau tangles, offering multiple ...
Medical News Today28d
Kisunla interactions: Alcohol, medications, and other factors
Kisunla (donanemab-azbt) is a brand-name injection for IV infusion prescribed for Alzheimer’s disease. Kisunla has no known interactions with alcohol, other drugs, or supplements. However ...
UPI6d
Study finds Alzheimer's drugs might boost healthy protein in brain
Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug Administration over the past two years.
Kearney Hub4d
'This is why we walk': New drug that may slow Alzheimers now offered in Kearney area
Kearney physician Dr. Bradley Rodgers will soon offer Kisunla, the first drug proven to slow the early onset of Alzheimer’s.
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Demand for Eli Lilly’s Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily ...
Hartsville patient one of first in U.S. to get new Alzheimer’s treatment
A Hartsville hospital patient is among the first in the United States to receive a new treatment that helps slow the ...
Healthline28d
Dosage Details for Kisunla
Kisunla (donanemab-azbt) is a prescription drug used to treat Alzheimer’s disease. The drug is given as an intravenous (IV) infusion by a healthcare professional. You’ll typically receive a ...
U.S. News & World Report6d
Alzheimer's Drugs May Work in Whole New Way, Study Finds
11, 2024 (HealthDay News) -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug ...
FiercePharma6d
On an expansion tear, Eli Lilly reveals $1.8B in investments at Irish manufacturing sites
Eli Lilly has again upped the ante in scaling up its manufacturing footprint, this time revealing an investment totaling $1.8 billion to expand production capacity at two plants in Ireland. | Eli ...